» Articles » PMID: 31057036

The Experience of Chemotherapy-Induced Peripheral Neuropathy Among Childhood Cancer Survivors

Overview
Publisher Sage Publications
Date 2019 May 7
PMID 31057036
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

As the number of childhood cancer survivors (CCS) is increasing, it is imperative to understand the late effects of childhood cancer therapy to optimize their health and quality of life. Chemotherapy-induced peripheral neuropathy (CIPN) is an unpleasant effect of chemotherapy that affects the peripheral nervous system. This qualitative study uses narrative analysis with a phenomenological influence to understand the lived experience of CIPN among five CCS utilizing photo-elicitation. The lived experience of CIPN is characterized by "a condition of disconnection" with three subthemes: (1) disconnection between mind and body, (2) disconnection between anticipated potential and reality, and (3) disconnection between survivors and support. The condition of disconnection leads to a variety of negative physical and emotional performance outcomes. These findings support the need for refined clinical strategies for identifying this underappreciated condition and further development of interventions to "rebuild the connections" that CCS are lacking.

Citing Articles

A new self-understanding as chemo sufferer - a phenomenological study of everyday life with chemotherapy induced neuropathy among survivors after colorectal cancer.

Jensen M, Morch C, Yilmaz M, Feilberg C, Pedersen B Int J Qual Stud Health Well-being. 2022; 17(1):2049437.

PMID: 35315728 PMC: 8942531. DOI: 10.1080/17482631.2022.2049437.


Longitudinal Evaluation of Neuromuscular Dysfunction in Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study.

Rodwin R, Chen Y, Yasui Y, Leisenring W, Gibson T, Nathan P Cancer Epidemiol Biomarkers Prev. 2021; 30(8):1536-1545.

PMID: 34099519 PMC: 8523186. DOI: 10.1158/1055-9965.EPI-21-0154.

References
1.
Hudson M, Ness K, Gurney J, Mulrooney D, Chemaitilly W, Krull K . Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013; 309(22):2371-2381. PMC: 3771083. DOI: 10.1001/jama.2013.6296. View

2.
Seretny M, Currie G, Sena E, Ramnarine S, Grant R, Macleod M . Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014; 155(12):2461-2470. DOI: 10.1016/j.pain.2014.09.020. View

3.
Friedrichsdorf S, Nugent A . Management of neuropathic pain in children with cancer. Curr Opin Support Palliat Care. 2013; 7(2):131-8. DOI: 10.1097/SPC.0b013e3283615ebe. View

4.
Armstrong T, Almadrones L, Gilbert M . Chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum. 2005; 32(2):305-11. DOI: 10.1188/05.ONF.305-311. View

5.
Bakitas M . Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nurs Res. 2007; 56(5):323-31. DOI: 10.1097/01.NNR.0000289503.22414.79. View